{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:04:21Z","timestamp":1758049461617,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.biopsych.2020.09.006","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T04:08:38Z","timestamp":1605499718000},"page":"896-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel Application for G Protein\u2013Biased Mu Opioid Receptor Agonists in Opioid Relapse Prevention"],"prefix":"10.1016","volume":"88","author":[{"given":"Amanda K.","family":"Fakira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2179-2874","authenticated-orcid":false,"given":"Lakshmi A.","family":"Devi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela J.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2020.09.006_bib1","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2020.09.006_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2019.10.020","article-title":"Toward directing opioid receptor signaling to refine opioid therapeutics","volume":"87","author":"Grim","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.09.006_bib3","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in beta-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2020.09.006_bib4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A\u00a0G protein-biased ligand at the mu-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine","volume":"344","author":"DeWire","year":"2013","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2020.09.006_bib5","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.biopsych.2020.02.014","article-title":"In a rat model of opioid maintenance, the G protein\u2013biased mu opioid receptor agonist TRV130 decreases relapse to oxycodone seeking and taking and prevents oxycodone-induced brain hypoxia","volume":"88","author":"Bossert","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.09.006_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuropharm.2019.02.008","article-title":"Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl","volume":"151","author":"Kiyatkin","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2020.09.006_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fnbeh.2019.00262","article-title":"Understanding addiction using animal models","volume":"13","author":"Kuhn","year":"2019","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.biopsych.2020.09.006_bib8","doi-asserted-by":"crossref","first-page":"107568","DOI":"10.1016\/j.drugalcdep.2019.107568","article-title":"Sex differences in prescription opioid use patterns assessed through a community engagement program in Florida","volume":"204","author":"Serdarevic","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2020.09.006_bib9","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: A neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.biopsych.2020.09.006_bib10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1124\/mol.112.083550","article-title":"Sex-biased stress signaling: The corticotropin-releasing factor receptor as a model","volume":"83","author":"Valentino","year":"2013","journal-title":"Mol Pharmacol"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322320319090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322320319090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:07:30Z","timestamp":1757776050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322320319090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0006322320319090"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2020.09.006","relation":{},"ISSN":["0006-3223"],"issn-type":[{"type":"print","value":"0006-3223"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Application for G Protein\u2013Biased Mu Opioid Receptor Agonists in Opioid Relapse Prevention","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2020.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2020.02.014","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}